New Treatment Option for Multidrug-Resistant Infections | Infection Control Todayhttps://www.infectioncontroltoday.com/infections/scientists-develop-new-treatment-option-multidrug-resistant-infections
2019-05 University of Liverpool study on tebipenem pivoxil hydrobromide
Pharmacodynamics of Tebipenem: New Options for Oral Treatment of Multi-Drug Resistant Gram-Negative Infections | Antimicrobial Agents and Chemotherapyhttps://aac.asm.org/content/early/2019/05/15/AAC.00603-19
2019-05 University of Liverpool study on tebipenem pivoxil hydrobromide
Study helps develop new treatment option for multi-drug resistant infectionshttps://medicalxpress.com/news/2019-05-treatment-option-multi-drug-resistant-infections.html
2019-05 University of Liverpool study on tebipenem pivoxil hydrobromide
Study helps develop new treatment option for multi-drug resistant infections | EurekAlert! Science Newshttps://www.eurekalert.org/pub_releases/2019-05/uol-shd052919.php
2019-05 University of Liverpool study on tebipenem pivoxil hydrobromide
UK research offers hope for new ways to tackle ‘superbugs’ | News | Nursing Timeshttps://www.nursingtimes.net/news/research-and-innovation/uk-research-offers-hope-for-new-ways-to-table-superbugs/7029134.article
2019-05 University of Liverpool study on tebipenem pivoxil hydrobromideCarbapenem-resistant bacteria

Showing topic

2019-05 University of Liverpool study on tebipenem pivoxil hydrobromide
Tebipenem pivoxil HBr (TBPM-PI-HBr)University of Liverpool